Transmedics Group Inc
TMDX
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.69B
Close$
$86.08
12.5% upside
Current Fair Value
12.5% upsideUndervalued by 12.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.69 Billion |
|---|---|
| Enterprise Value | $3.09 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $5.6 |
| Beta | 1.93 |
| Outstanding Shares | 34,579,980 |
Return
| Return on Equity | 29.28% |
|---|---|
| Return on Assets | 10.36% |
| Return on Invested Capital | 6.69% |
Valuation & Multiples
| P/E Ratio | 17.62 |
|---|---|
| PEG | -30.41 |
| Price to Sales | 4.03 |
| Price to Book Ratio | 5.47 |
| Enterprise Value to Revenue | 4.62 |
| Enterprise Value to EBIT | 33.79 |
| Enterprise Value to Net Income | 20 |
| Total Debt to Enterprise | 0.28 |
| Debt to Equity | 1.68 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 4, 2026
EPS Estimate
$0.50
Average shareholder expectationRevenue Estimate
$184.00 M
Average shareholder expectationNext Earnings Call
Expected Date
November 4, 2026
EPS Estimate
$0.30
Average shareholder expectationRevenue Estimate
$178.05 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 118.69% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.56%▼ 100.05% |
|---|---|
| Total Invested | $45.10M▼ 98.07% |
| Investors Holding | 14▼ 391.00% |
ESG Score
No data